- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01377558
Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes
Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes - Aerobic Endurance Training Versus Strength Endurance Training Versus Combined Aerobic Endurance and Strength Endurance Training -
The purposes of the study are
- to determine which kind of supervised exercise intervention (aerobic endurance training versus strength endurance training versus combined aerobic endurance and strength endurance training) is more effective in improving the metabolic parameters in typ 2 diabetes patients
- to investigate what kind of intervention is more successful in reduction of concomitant diseases and improving quality of life
- to assess what kind of intervention induces highest effects in long term persistence of these positive changes
Study Overview
Status
Conditions
Detailed Description
Meta-analyses which evaluated the effects of structured exercise programs in patients with type 2 diabetes demonstrate that regular physical activity improves glycosylated haemoglobin (König et al.: Resistance Exercise and Type 2 Diabetes Mellitus, Deutsche Zeitschrift für Sportmedizin Jahrgang 62, Nr. 1 (2011): 5-9). Sigal et al. proved that either aerobic or resistance training alone improved glycemic control in type 2 diabetes, but the improvements are greatest with combined aerobic and resistance training (Sigal, RJ, et al.: Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes, Ann Intern Med. 2007 Sep 18;147(6):357-69).
Therefore, aim of the current study is to compare the effects of aerobic endurance training or resistance endurance training or the combination of aerobic endurance training and resistance endurance training in diabetes type 2 patients without any other lifestyle or dietary interventions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hessen
-
Giessen, Hessen, Germany, 35394
- University of Gießen
-
-
Sachsen
-
Zwickau, Sachsen, Germany, 08056
- Sportpark Zwickau, Glauchau, Meerane
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnoses of type 2 diabetes (ADA criteria)
- admitted diabetes treatments will be diet and oral hypoglycemic agents
Exclusion Criteria:
- sports intervention >60 minutes per week
- medical conditions
- preproliferative or proliferative retinopathy
- instable coronary heart disease
- inability to perform the scheduled physical activity programs
- acute clinically significant intercurrent diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Aerobic endurance training intervention
Aerobic endurance training
|
The aerobic endurance training group will use cardiovascular training devices week 1-4: 15 minutes warm up (group) 15 minutes intervention at 80-100% vAT two times per week week 5-13: 15 minutes warm up (group) 30 minutes intervention at 95-110% vAT two times per week week 14-26: 15 minutes warm up (group) 45 minutes intervention at 95-110% vAT two times per week
Other Names:
|
Experimental: Strength endurance training intervention
Strength endurance training
|
The strength endurance training intervention group will perform eight exercises on weight machines (Milon circuit training- 60 seconds activity, 30 seconds break) week 1-4: 15 minutes warm up (group) 1 session resistance training intensity 3 (Buskies) two times per week week 5-13: 15 minutes warm up (group) 2 sessions resistance training intensity 5 (Buskies) two times per week week 14-26: 15 minutes warm up (group) 3 sessions resistance training intensity 5 (Buskies) two times per week
Other Names:
|
Experimental: Combined training intervention
Combined aerobic endurance training and strength endurance training intervention
|
week 1-4: 15 minutes warm up (group) 15 minutes intervention at 80-100% vAT once per week and 15 minutes warm up (group) 1 session resistance training intensity 3 (Buskies) once per week week 5-13: 15 minutes warm up (group) 15 minutes intervention at 95-110% vAT and 1 session resistance training intensity 5 (Buskies) two times per week week 14-26: 15 minutes warm up (group) 30 minutes intervention at 95-110% vAT and 1 session resistance training intensity 5 (Buskies) once a week and 15 minutes warm up (group) 15 minutes intervention at 95-110% vAT and 2 sessions resistance training intensity 5 (Buskies) once a week |
No Intervention: Control group
control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in HbA1c-level (haemoglobin A1c)
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in HOMA-Index
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in beta-cell-function
Time Frame: 3 and 6 months
|
Measured by OGTT (Oral Glucose Tolerance Test)
|
3 and 6 months
|
Change in fasting plasma glucose levels
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in total cholesterol levels
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in HDL-cholesterol levels
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in LDL-cholesterol levels
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in triglyceride levels
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in antidiabetic medications
Time Frame: 3 and 6 months
|
Class and dosage of blood-glucose lowering drugs are recorded before, after 3 and 6 months
|
3 and 6 months
|
Change in inflammation markers
Time Frame: 3 and 6 months
|
CrP, blood count, interleukinstatus, cytokinstatus
|
3 and 6 months
|
Change in body weight
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in body composition
Time Frame: 3 and 6 months
|
by Bio-impedance analysis, waist to hip ratio, range of thigh
|
3 and 6 months
|
Change in strength
Time Frame: 3 and 6 months
|
by Dr. Wolff Back Check
|
3 and 6 months
|
Change of maximum heart rate
Time Frame: 3 and 6 months
|
Measured by an incremental exercise test
|
3 and 6 months
|
Change of peak oxygen uptake
Time Frame: 3 and 6 months
|
Measured by an incremental exercise test
|
3 and 6 months
|
Change of vAT (ventilatory anaerobic threshold)
Time Frame: 3 and 6 months
|
Measured by an incremental exercise test
|
3 and 6 months
|
Change in blood pressure
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in renal function
Time Frame: 3 and 6 months
|
Creatininlevel, Albuminlevel (urine), Telomere length
|
3 and 6 months
|
Change in concentration
Time Frame: 3 and 6 months
|
by d2-test
|
3 and 6 months
|
Change in quality of life
Time Frame: 3 and 6 months
|
by questionnaire: SF-12, EQ5
|
3 and 6 months
|
Change of nutrition
Time Frame: 3 and 6 months
|
by questionnaire: FEV, FFQ
|
3 and 6 months
|
Change in voluntary physical activity
Time Frame: 3 and 6 months
|
meassured by pedometer (one week)
|
3 and 6 months
|
Change of cardiac output by Impedance cardiography
Time Frame: 3 and 6 months
|
by Task Force Monitor
|
3 and 6 months
|
Change of barorezeptorsensitivity
Time Frame: 3 and 6 months
|
by Task Force Monitor
|
3 and 6 months
|
Change in carotid-Intima-Media-Thickness
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in aortic pulse-wave velocity
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change in central aortic pressure
Time Frame: 3 and 6 month
|
3 and 6 month
|
|
Change in endothelial dysfunction
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Change of parodontitis
Time Frame: 3 and 6 months
|
3 and 6 months
|
|
Follow up of all parameters mentioned above
Time Frame: after 12 months
|
Follow up after 12 months (6 months after completing the exercise intervention) without any supervised intervention
|
after 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Andree Hillebrecht, Dr. med., University of Gießen
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Gi-03-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on Aerobic endurance training intervention
-
Molde University CollegeNorwegian University of Science and TechnologyCompletedHealthy
-
Universitätsmedizin MannheimUnknownMorbid ObesityGermany
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedHyperglycemia | Diabetes Mellitus, Type 2Norway
-
Universität Duisburg-EssenCompleted
-
Rigshospitalet, DenmarkCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States
-
University Hospital, AntwerpUniversitaire Ziekenhuizen KU Leuven; KU LeuvenUnknownPercutaneous Coronary Intervention (PCI) | Coronary Artery Disease (CAD); | Myocardial Infarction (MI) | Coronary Artery Bypass Grafting (CABG)Belgium
-
University of LeipzigGerman Research FoundationCompletedHeart Failure | AgeingGermany
-
University of LeipzigDeutsche Stiftung für HerzforschungCompleted
-
KU LeuvenResearch Foundation FlandersCompleted